prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, PATIENT HISTORY: SPECIMENS TAKEN BY PATH DATE of LMP: (NOT LISTED ON REQUISITION). DATE or LAST DELIVERY: PRE-OP DIAGNOSIS: RIGHT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SENTINEL LYMPH NODE, R SEGMENTAL MASTECTOMY. CLINICAL HISTORY: SPECIMENS TAKEN BY PATH. MATERIAL SUBMITTED: A) RIGHT SENTINEL LYMPH NODE, PROCUREMENT BY SURGICAL PROCEDURE. B) RIGHT BREAST BICPSY/TISSUE, PROCUREMENT BY SURGICAL PROCEDURE. Long-lat,med-med, sht-superior. INTRAOPERATIVE CONSULTATION: R SENTINEL LYMPH NODE #1: One lymph node, 0.8 by 0.6 by 0.5 cm. Touch Prep. Diagnosis: Negative. ADDENDA: Addendum. FISH analysis using DNA probe for Her-2/neu gene showed that, the ratio of Her-2/neu signals to chromosome 17. centromere signais is 0.94 (> 2.0 ratio is considered amplified). Therefore, Her-2/neu gene is not amplified. Bv Pathologi. My signature is attestation that I have personally reviewed the submitted material(s) and the above diagnosis reflects that evaluation. Addendum. MATERIAL SUBMITTED: BLOCK "B3" FOR ER/PR AND HER-2/NEU (BREAST CANCER). FINAL DIAGNOSIS: ESTROGEN/PROGESTERONT RECEPTORS AND HER-2/NEU PERFORMED ON RIGHT BREAST TISSUE. ESTROGEN RECEPTOR (0- 40%; 1+ 40%; 2+ 10%; 3+ 10%) HSCORE OF 90. ESTROGEN RECEPTOR IS INTERPRETED AS. POSITIVE. PROGESTERONS RECEPTOR (0- 70%; 1+ 10%; 2+ 10%; 3+ 10%) HSCORE OF 60. PROGESTERONI RECEPTOR IS INTERPRETED AS. POSITIVE. HER-2/NEU-DAKO HERCEPTEST. A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE THAN 10% OF THE. TUMOR CELLS. HER-2/NEU IS INTERPRETED AS POSITIVE (SCORE 2+). HSCORE: <= 15 NEGATIVE. >15<=30 BORDERLINE. FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) RIGHT SENTINEL LYMPH NODE #1: - MICROMIETASTATIC DUCTAL CARCINOMA OF THE BREAST (SEE NOTE). B) RIGHT SEGMENTAL MASTECTOMY: INFILTRATING MODERATELY DIFFERENTIATED DUCTAL CARCINOMA) NOTTINGHAM SCORE 6/9 (TUBULES=3, NUCLEI=2,. MITOSIS-1) SIZE 2.5 BY 2.0 BY 1.5 CX. - DUCTAL CARCINOMA IN SITU, NON-COMEDO TYPE, SOLID AND CRIBRIFORK) NUCLEAR GRADK 1, CONSTITUTES 5% or. ENTIRE. TUMOR MASS. - SEVERAL MICROSCOPIC FOCI OF INFILTRATING ADENOCARCINOMA, UP TO 0.5 CM, IN THE REMAINING BREAST TISSUE. #9, #12). - LATERAL AND INFERIOR SURGICAL MARGINS POSITIVE FOR INVASIVE TUMOR. - INTRADUCTAL PAPILLOMA AND PROLIFERATIVE FIBROCYSTIC CHANGES IN THE REMAINING BREAST TISSUE. FOCAL NECROSIS AND GRANULATION TISSUL, STATUS-POST CORE BIOPSY or BREAST (CROSS REFER. NOTE: Minute clusters of metastatic ductal carcinoma was found in serial section "Al", but it ie best. visualized with the immunoperoxidase stain AB1/AR3 in serial section A2. The immunostain was repeated and. the presence of metastatic neoplastic cells in the lymph node section "Al" was confirmed by. immunostaining ("A26A3"). The later serial sections of the lymph nodes are negative. The touch prep of. the. sentinel node was re- reviewed and no malignant cells are identified ER/PR immunoperoxidase assay and Her-. 2/NEU testing will be performed on block "B3". The special stains and/or immunoperoxidase tests used in thi ~ase hatra bean and their performance. characterietics determined by the Department of Pathology at. They have not been cleared or approved by the U.S. Food and Drug Administration.

expanded version (tokens=1469) : 
 The breast pathology report indicates the following:

1. Histological classification:
    a) Infiltrating moderately differentiated ductal carcinoma along with minute clusters of metastatic ductal carcinoma in the right sentinel lymph node (#1).
    b) Ductal carcinoma in situ (DCIS), non-comedo type, solid, and cribriform, with a nuclear grade of 1, constituting 5% of the entire tumor mass.
    c) Several microscopic foci of infiltrating adenocarcinoma, up to 0.5 cm in size, in the remaining breast tissue.
    d) Intraductal papilloma and proliferative fibrocystic changes in the remaining breast tissue.

2. Subtype:
    a) Luminal A subtype

3. Necrosis:
    a) Focal necrosis and granulation tissue noted.

4. Tumor infiltrating lymphocytes:
    a) No mention of tumor infiltrating lymphocytes noted.

5. Histological grade:
    a) Nottingham score of 6 out of 9 (tubules=3, nuclei=2, mitosis=1)

6. Nuclear grade:
    a) Nuclear grade of 1 for DCIS component

7. Lymphovascular invasion:
    a) No mention of lymphovascular invasion noted.

8. Calcification:
    a) No mention of calcification noted.

9. Receptor status:
    a) Estrogen receptor (ER) -

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1634) : 
 The breast pathology report of a luminal A subtype patient revealed Infiltrating moderately differentiated ductal carcinoma and minute clusters of metastatic ductal carcinoma in the right sentinel lymph node (#1). The patient also had DCIS, non-comedo type, solid and cribriform with a nuclear grade of 1 and intraductal papilloma, proliferative fibrocystic changes in the remaining breast tissue. Lateral and inferior margins were positive for invasive tumor. ER and PR are positive while HER-2/neu is interpreted as positive with a score of 2+.

